Curaleaf strengthens its management team with three key recruits — Greenway Magazine


Ed Kremer joins as CFO, Camille Lyon is named Chief Investment Officer and Mitch Hara takes on the new position of Chief Strategy Officer

Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, announced three new hires joining the team management of the company this month. Ed Kremer will join as Chief Financial Officer, Camille Lyon was appointed Chief Investment Officer, and Mitch Hara will be director of strategy, a new role within the company. Mr. Kremer and Mr. Lyon will start August 8 and Mr. Hara have joined in force August 3.

The news falls like Matt Darin, who was named CEO of Curaleaf in February this year, focused his first few months of leadership on reshaping the business for long-term success, and on the heels of record second quarter results, the first under Darin as CEO. In May, Darin named Tyneeha Rivers the company’s first Chief Human Resources Officer, to continue to lead Curaleaf’s culture and become the destination for the highest level of talent in the industry.

Newly appointed Chief Financial Officer Ed Kremer recently worked in the cannabis industry and brings extensive experience as a public CFO and leader at companies such as Oakley, Beats by Dre and Olivier Peoples. neil davidsonActing CFO of Curaleaf, will work closely with Mr. Kremer during the transition period.

Camille Lyon will lead capital markets and investor relations as Curaleaf’s first Chief Investment Officer. Mr. Lyon most recently worked as Managing Director at BTIG, where he covered the consumer and cannabis industries. He brings over 20 years of finance experience and a wealth of knowledge and relationships to this position.

In the new role of Chief Strategy Officer, Mitch Hara will oversee corporate strategy functions, including mergers and acquisitions, international, and research and development. Mr. Hara brings years of experience as a seasoned Wall Street and cannabis strategist, trader and trader, most recently as Head of Mergers & Acquisitions and Business Development at Clever Leaves International.

Chief executive officer Matt Darin said, “From the first day I took on the role of CEO, I have been relentlessly focused on three key areas: leadership and culture, operational excellence, and delivering quality products and brands to large scale. I firmly believe that the foundation of all successful organizations is leadership and culture, and I am confident that these three hires will secure Curaleaf’s future as a global leader in product innovation, brands, quality and safety, legislative reform efforts, CSR and of course, Talent. Ed, Camilo and Mitch all bring strong industry experience; track record of discipline, growth and success in business; and smart strategic ideas that will enable Curaleaf to achieve our long-term goals. I am delighted to welcome them to the management team and would like to thank neil davidson for his continued commitment and contributions to Curaleaf.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer cannabis products whose mission is to improve lives by bringing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for its quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility in medical markets. and adults. In United States, Curaleaf currently operates in 22 states with 136 dispensaries, 26 cultivation sites and employs more than 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, combining pioneering science and research with state-of-the-art cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit


This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “proposed”, “is expected”, “intends” , “anticipates” or “believes”. ”, or variations of these words and expressions, or by the use of words or expressions indicating that certain actions, events or results can, could, could occur or be achieved. Specifically, and without limitation, this press release contains forward-looking statements and information regarding the hiring of Ed Kremer as Chief Financial Officer, Mitch Hara as Director of Strategy and Camille Lyon as Chief Investment Officer.

These forward-looking statements and information reflect the current beliefs of management and are based on assumptions made by and information currently available to the company with respect to the subject matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. understood by these statements. Additional information on these assumptions and risks and uncertainties is contained in the “Risk Factors and Uncertainties” section of the Company’s most recently filed Annual Information Form. March 9, 2022, which is available under the Company’s SEDAR profile at, and in other documents the Company has filed and may file with applicable securities authorities in the future . The forward-looking statements contained herein are made only as of the date of this press release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place significant reliance on any forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved of the contents of this press release.

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.
Tracy Bradysenior vice president of corporate communications


Comments are closed.